Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032285 (
pneumonia
)
54,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mycoplasma hyopneumoniae
(
M. hyopneumoniae
) is the causative agent of pandemic
pneumonia
among pigs, namely, swine enzootic
pneumonia
. Although
M. hyopneumoniae
was first identified in 1965, little is known regarding its metabolic pathways, which might play a pivotal role during disease pathogenesis. Lipoate is an essential cofactor for enzymes important for central metabolism. However, the lipoate metabolism pathway in
M. hyopneumoniae
is definitely unclear. Here, we identified a novel gene, lpl, encoding a lipoate protein ligase in the genome of
M. hyopneumoniae
(Mhp-Lpl). This gene contains 1,032 base pairs and encodes a protein of 343 amino acids, which is between 7.5 and 36.09% identical to lipoate protein ligases (Lpls) of other species. Similar to its homologs in other species, Mhp-Lpl catalyzes the ATP-dependent activation of lipoate to lipoyl-
AMP
and the transfer of the activated lipoyl onto the lipoyl domains of
M. hyopneumoniae
GcvH (Mhp H)
in vitro
. Enzymatic and mutagenesis analysis indicate that residue K56 within the SKT sequence of Mhp H protein is the lipoyl moiety acceptor site. The three-dimensional structure showed typical lipoate protein ligase folding, with a large N-terminal domain and a small C-terminal domain. The large N-terminal domain is responsible for the full enzymatic activity of Mhp-Lpl. The identification and characterization of Mhp-Lpl will be beneficial to our understanding of
M. hyopneumoniae
metabolism.
...
PMID:Functional Identification and Structural Analysis of a New Lipoate Protein Ligase in
Mycoplasma hyopneumoniae
. 3237 50
<< Previous
1
2
3